Next Article in Journal
Dependence of GaN Exciton Energy on Temperature
Next Article in Special Issue
Polymorphism of the Transition Metal Oxidotellurates NiTeO4 and CuTe2O5
Previous Article in Journal
Simulation-Based Studies on FAGeI3-Based Lead (Pb2+)-Free Perovskite Solar Cells
Previous Article in Special Issue
Crystallographic and Thermal Studies of the Polymorphs of Tetraoxa[4]arene with Meta-Phenylene Linkers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Four Polymorphs of the Bioactive Diuretic Drug 4-Chloro-5-chlorosulfonyl Salicylic Acid

by
Maria Olimpia Miclaus
,
Gheorghe Borodi
and
Alexandru Turza
*
National Institute for R&D of Isotopic and Molecular Technologies, Donat 67-103, 400293 Napoca, Romania
*
Author to whom correspondence should be addressed.
Crystals 2025, 15(2), 136; https://doi.org/10.3390/cryst15020136
Submission received: 20 December 2024 / Revised: 20 January 2025 / Accepted: 24 January 2025 / Published: 26 January 2025
(This article belongs to the Special Issue Crystalline Materials: Polymorphism)

Abstract

:
4-chloro-5-chlorosulfonyl salicylic acid [C7H4Cl2O5S] is a derivative of salicylic acid and a diuretic agent. Its ability to form polymorphs through recrystallization from various solvents was demonstrated. As a result, four polymorphs were successfully obtained and analyzed using single-crystal X-ray diffraction and powder X-ray diffraction, which represents a novelty regarding the polymorphism of this compound of pharmaceutical interest. The solid-state properties were investigated by evaluating crystal lattice energies and intermolecular interactions.

Graphical Abstract

1. Introduction

Salicylic acid is a naturally occurring compound and a plant hormone [1], which is currently widely used in various applications, such as for treating skin conditions [2,3,4,5,6], as a food preservative, and for its antiseptic and bactericidal properties [7].
The derivatives of salicylic acid have been employed in the synthesis of various pharmaceutical active ingredients. The title compound (Figure 1) is a diuretic agent that is used as a reagent in the synthesis of the diuretic drug xipamide [8,9].
The CSD database and the literature report a limited number of structures of salicylic acid derivatives with various substitutions, including studies on polymorphism [10,11,12], solid-state crystal packing, and hydrogen bonding investigations [13,14]. However, the title compound has not yet been studied in this context.
The current research aims to obtain polymorphs of this compound, primarily based on the functional groups it contains: carbonyl (C=O) and carboxyl (R-COOH). These groups have an increased affinity for participating in the formation of new hydrogen bonds and supramolecular synthons, leading to the formation of polymorphs. Polymorphism refers to the potential of a chemical compound to adopt different molecular self-arrangements from a crystallographic point of view [15,16]. The pursuit of new polymorphs of a pharmaceutical compound with biological activity is driven by the desire to obtain crystalline forms with improved solubility, bioavailability, and melting points [17]. Such studies regarding the analysis of polymorphs of pharmaceutical compounds can be mentioned [18,19,20,21].
We report the identification of four polymorphs of the diuretic drug 4-chloro-5-chlorosulfonyl salicylic acid. Their crystal structures were elucidated using single-crystal X-ray diffraction and further investigated by powder X-ray diffraction. Solid-state analysis was performed using Hirshfeld surfaces, and lattice energy was evaluated.

2. Materials and Methods

2.1. Single Crystal Growth Experiments

The sample of 4-chloro-5-chlorosulfonylsalicylic acid was purchased from Microsin, Bucharest, while the used solvents were received from Merck, Germany. Crystals suitable for X-ray diffraction data collection were obtained through high-throughput screening using the Crissy XL light crystallization device, which can handle up to 24 experiments simultaneously to identify new solid crystalline forms. The solvents and various solvent mixtures were gradually mixed with the material in three successive steps, resulting in 1 mL of final solution with the sample completely dissolved. Crystals that are suitable for analysis were successfully obtained through gradual evaporation as follows:
(i)
Polymorph 1 was obtained from a methanol solution;
(ii)
Polymorph 2 was crystallized in acetonitrile;
(iii)
Polymorph 3 was obtained from a 1:1 mixture of ethanol and acetone;
(iv)
Polymorph 4 was obtained from a tetrahydrofuran solution.
An important note is that that the polymorphs 2 and 3 were not further reproduced anymore in order to conduct other experimental investigations to assess their properties.

2.2. X-Ray Single Crystal Diffraction and Structure Refinement

Appropriate single crystals of the polymorphs were attached on a fine nylon loop using inert oil and analyzed with a SuperNova diffractometer, operating at 50 kV and 0.8 mA. The diffractometer possesses dual Cu and Mo radiation sources, along with an Eos CCD detector. The CrysAlis PRO package [22] was used for data collection, reduction, and implementation of the corrections for Lorentz, polarization, and absorption effects.
The structures were treated and solved with Olex2 software (version 1.2.10) [23], using the ShelXL solution program with Direct Methods for Polymorphs 1, 2, and 3, which were solved by SHELXS [24] via direct methods, while Polymorph 4 was solved using the SHELXT [25] with Intrinsic Phasing. The structures were refined by Least Squares minimization implemented in SHELXL [26].
C-bound hydrogen atoms were treated as riding with CH groups with distances of 0.98 Å. O-bound hydrogen atoms were located based on the Fourier maps and refined with a distance of O-H = 0.82 Å.

2.3. X-Ray Powder Diffraction Analysis

The diffraction data on powders were collected with a Bruker D8 Advance diffractometer using CuKα1 radiation in the angular range of 2θ = 5–40°.

2.4. Computational Chemistry

The intermolecular interactions were examined in the context of strength (magnitudes) and nature for asymmetric units and their neighboring molecules located at distances equal to or less than the sum of their van der Waals radii (which describes the spatial boundaries within which atoms exert attractive forces). Pairwise interaction energies were calculated considering four distinct energy components: electrostatic term (Eele), polarization term (Epol), dispersion term (Edis), and the exchange repulsion term (Erep) [27,28]. These computations were conducted via the [B3LYP/6-31G(d,p)] function in the CrystalExplorer package [27]. The scaling factors for the CE-B3LYP model are as follows: kele = 1.057, kpol = 0.740, kdisp = 0.871, and krep = 0.618. Additionally, both C-H and O-H bond lengths were adjusted to the normalized bond lengths used in neutron diffraction, with C-H = 1.083 Å and O-H = 0.993 Å [29].
The evaluation of crystal lattice energies was conducted via the CrystalExplorer package [27], considering a cluster of molecules around the asymmetric units with a distance of 45 Å.

3. Results

3.1. Descriptions of the Crystal Structures

Table 1 presents the detailed crystallographic and refinement data of the analyzed crystals.

3.1.1. Polymorph 1

The starting form of 4-chloro-5-chlorosulfonylsalicylic acid crystallizes centrosymmetrically in the monoclinic C2/c space group, with one molecule in the asymmetric unit (Figure 2a). In the crystal, the molecules are linked via mutual O1-H1···O2 carboxyl···carboxyl hydrogen bonds (1.656 Å), which bridge molecular dimers and form a R22(8) graph set motif. Along the b-axis direction, the molecules are linked via C4-H4···O4 interactions (2.441 Å) between the phenyl ring and the O4 oxygen of the sulfonyl group and are located in the same plane. The molecular layers are further connected via O3-H3···O5 (2.485 Å) hydrogen bonds between the hydroxyl group and the O5 sulfonyl oxygen. The crystal packing perspective of polymorph 1 is depicted in Figure 2b.

3.1.2. Polymorph 2

Polymorph 2 was discovered to crystallize centrosymmetrically with one molecule in the asymmetric unit (Figure 3a), but it belongs to the triclinic P-1 space group. Its packing similarities are high, as it once again forms R22(8) molecular synthons that link molecular dimers via strong O1-H1···O2 carboxyl···carboxyl hydrogen bonds (1.695 Å). Other similarities include the presence of C4-H4···O4 interactions (2.303 Å) between the phenyl ring and the O4 sulfonyl oxygen, which occur this time in the direction of the a-axis and connect diuretic molecules located in the same plane. The adjacent molecular layers are further connected via O3-H3···O5 (2.383 Å) hydrogen bonds between the hydroxyl group and the O5 sulfonyl oxygen. Polymorph 2 is packed along the a-axis, as depicted in Figure 3b.

3.1.3. Polymorph 3

Polymorph 3 crystallized centrosymmetrically and belongs to the monoclinic P21/c crystal system, with one molecule in the asymmetric unit (Figure 4a). The structure is characterized by reciprocal O1-H1···O2 carboxyl···carboxyl hydrogen bonds (1.708 Å), which bind together to form a dimer that exhibits an R22(8) graph set motif. The difference in crystal packing compared to polymorphs 1 and 2 lies in the π···π interactions, which occur between the C4···C4 phenyl rings at a distance of 3.393 Å, leading to the formation of molecular layers located in the same plane (Figure 4b).

3.1.4. Polymorph 4

By X-ray single crystal analysis, it was found that, similarly to polymorph 3, the fourth polymorph investigated crystallized in the centrosymmetric P21/c space group of the monoclinic crystal system, with one polymorph 4 molecule in the asymmetric unit (Figure 5a). As in the case of the other crystals, polymorph 4 consists of molecular dimers that form R22(8) motifs based on the formation of reciprocal O1-H1···O2 carboxyl···carboxyl hydrogen bonds (1.689 Å). The molecules are linked in the direction of the c-axis via O3-H3···O5 (2.6 Å) hydrogen bonds between the O1 hydroxyl atom and the O5 oxygen of the sulfonyl group, forming infinite chains that depict a sinusoidal-like shape (Figure 5b).
The molecular packing similarity analysis for the four polymorphs was performed using the Mercury software package (Version 2023 3.0) [30], which calculated positional differences between a cluster of 15 molecules in each crystal [31]. The parameters were set to include only molecules with a positional variation within 20% for both distances and angles, while molecules with deviations greater than 20% were excluded. Hydrogen atom positions were omitted, and inversions were allowed during the comparison. The results show that polymorphs 1 and 2 have the highest packing similarity, with five out of 15 molecules overlapping and an RMS deviation of 0.348. Polymorphs 2 and 4 also exhibit a good overlap for three of the 15 molecules, with an RMS deviation of 0.106, while the remaining molecules align well only for the molecular pairs that form the R22(8) synthons. The molecular overlap is displayed in Figure S1 (Supplementary Materials).
The analysis of the four crystal structures reveals several key structural features as follows:
(i)
All polymorphs crystallized in centrosymmetric space groups: monoclinic C2/c for polymorph 1, triclinic P-1 for polymorph 2, and monoclinic P21/c for polymorphs 3 and 4.
(ii)
The polymorphs are characterized by asymmetric units consisting of single diuretic molecules.
(iii)
All four polymorphs exhibit molecular dimers based on the formation of R22(8) homosynthons via strong O-H···O mutual hydrogen bonds.
(iv)
In terms of molecular layout, polymorph 1 differs from polymorphs 2, 3, and 4 due to the twisted chlorosulfonyl group.

3.2. Powder X-Ray Diffraction

X-ray diffraction analysis was performed to assess the structural homogeneity and purity of the prepared samples, as well as to confirm that the analyzed single crystals are representative of the entire bulk powder sample. Comparisons between the simulated diffraction patterns (generated from the CIF files) and the experimental patterns are shown in Figure S2 (Supplementary Materials). A good match is observed in all paired comparisons, except for some diffraction intensities that are lower in the experimental patterns, which can be attributed to the preferred orientation of the crystallites.

3.3. Hirshfeld Surface Analysis

The Hirshfeld surface analysis was carried out to gain a deeper understanding of the contact interactions in the crystal structures of the polymorphs. The analysis reveals both similarities and differences among the polymorphs in terms of distinct contact features (Table 2), as demonstrated by the corresponding dnorm-surface mappings in Figure 6.
The code of colors refers to the distribution of intermolecular contact distances between atoms on the surface of a molecule and is used to visualize the nature and strength of interactions, such as van der Waals forces, hydrogen bonding, or other intermolecular forces. Red represents regions where atoms from neighboring molecules are very close to the surface, indicating strong interactions; white represents points where the intermolecular distances are similar to the sum of the van der Waals radii (∑vdW) of the involved atoms, signifying neutral or weak contacts; blue indicates areas where the intermolecular distance is relatively large, suggesting very weak or no interaction
The most obvious similarity observed in all four polymorphs is the presence of deep paired red areas that correspond to intermolecular O1-H1···O2 contacts. The deep red color suggests that these interactions are strong, which is also evident from the separation distances, which are significantly shorter compared to the sum of the van der Waals radii (Table 2). Polymorph 1 shows a contact distance for the O1-H1···O2 of 1.666 Å, in polymorph 2 the distance is 1.705 Å, in polymorph 3 it is 1.718 Å, and in polymorph 4 it is 1.698 Å, all of which are considerably shorter than the ∑vdW of 2.72 Å.
Other similarities were found in polymorphs 1, 2, and 3 in terms of the O3-H3···O5 contact (2.490 Å vs. ∑vdW = 2.72 Å in polymorph 1, 2.387 Å vs. ∑vdW = 2.72 Å in polymorph 2, and 2.606 Å vs. ∑vdW = 2.72 Å in polymorph 3), which can be seen as two pale red spots on the surfaces in polymorphs 1 and 2, while in polymorph 3 they appear as white patches since they are very close to the ∑vdW.
The presence of the C4-H4···O4 hydrogen bond between the phenyl ring and the chlorosulfonyl functional group is seen as a pale red spot in both structures of polymorphs 1 and 2 (2.445 Å vs. ∑vdW = 2.72 Å in polymorph 1 and 2.308 Å vs. ∑vdW = 2.72 Å in polymorph 2), but it is not present in polymorphs 3 and 4.
A unique feature that can be observed in polymorph 3, but is lacking in the others, is the white patches indicative of π···π interactions, which are very close to the van der Waals sum limit in separation distance (3.393 Å vs. ∑vdW = 3.40 Å). Another interaction that can be distinguished in polymorphs 3 and 4 are the C-H···Cl interactions, characterized by white spots on the Hirshfeld surfaces (2.949 Å vs. ∑vdW = 2.95 Å and 2.925 Å vs. ∑vdW = 2.95 Å).
Other non-traditional intermolecular interactions identified by faint red spots and white patches on the Hirshfeld surfaces include O···C, C···Cl, O···Cl, and Cl···Cl contacts.
The breakdown of various close contacts for the polymorphs was carried out by analyzing the fingerprint plots and the di and de distances (Figure 7 and Figure 8).
As a first similarity, all fingerprint diagrams are paw-like in shape and symmetrical, due to the fact that the crystals are characterized by a single molecule in the asymmetric unit. All four crystals are dominated by H···O/O···H contacts, which represent 27.2% in polymorph 1, 31.0% in polymorph 2, 25.3% in polymorph 3, and 23.6% in polymorph 4. These are distinguished on the fingerprint plots as two sharp protruding spikes, suggesting that the O-H···O interactions play an important role in cohesion.
The second contribution to the fingerprint plots is from Cl···O/O···Cl contacts, which account for 16.8% in polymorph 1, 14.7% in polymorph 2, and 20.6% in both polymorphs 3 and 4. The third contribution is from H···Cl/Cl···H contacts, which appear as symmetrical wings on the plots of polymorphs 2, 3, and 4, while in polymorph 1 they are less prominent. A common feature seen in all crystals is the lack of prominent H···H spikes on the fingerprint plots; these contacts account for only 7.2% in polymorph 1, 4.3% in polymorph 2, 3.3% in polymorph 3, and 4.7% in polymorph 4.
Moreover, the C···H/H···C contacts exhibit a similar pattern in all polymorphs and are characterized by distances longer than the ∑vdW, accounting for 5.8% in polymorph 1, 4.3% in polymorph 2, 6.1% in polymorph 3, and a higher percentage of 9.1% in polymorph 4.
The Hirshfeld and fingerprint plot analysis concludes that the hydrogen bonding and other van der Waals interactions are governing the crystal cohesion.
The Hirshfeld surfaces were also mapped with the electrostatic potential (Figure S3, Supplementary Materials), highlighting the complementarity of charges between various interactions found on the Hirshfeld surfaces. The electrostatic potential mappings reveal that the identified donor and acceptor atoms, being charge-complemented, attract each other electrostatically.

3.4. Intermolecular Interaction Energies

The intermolecular contacts identified were analyzed through interaction energy evaluation to assess the relative strength of various contacts within the crystals for a cluster with molecules located at distances up to 3.8 Å from the central molecule. The results are presented interactively in Figure S4 (Supplementary Materials). Table 3 presents a summary of the most relevant interactions.
In all four polymorphs, the strongest interactions are similar and occur within the formation of eight-membered R22(8) homosynthons via the mutual O1-H1···O2 hydrogen bonds. Thus, polymorph 1 displays a value of −59.8 kJ/mol, polymorph 2 shows −59.5 kJ/mol, polymorph 3 exhibits −55.9 kJ/mol, and polymorph 4 shows −58.1 kJ/mol. All these intermolecular interactions are primarily driven by the dominant electrostatic term, which was found to be −115.0 kJ/mol in polymorph 1 and −101.0 kJ/mol in polymorph 3.
Even though the separation distances between stacked molecular layers are longer than the ∑vdW radii, the dispersion energy is significant enough for their combined contributions to become important. Note that polarization forces are the least significant in all polymorphs.
Energy framework simulations were conducted to assess the impact of overall interaction forces on the packing behavior of the four polymorph crystals. As depicted in Figure 9, the molecular packing of the polymorphs is primarily stabilized by electrostatic forces (illustrated by red bars), particularly the strong O1-H1···O2 hydrogen bond interactions, along with the long-range molecular stacking interactions that account for the dispersion forces (green bars), even though their separation distances are shorter than those to the ∑vdW only in Polymorph 3.

3.5. Crystal Lattice Energies in Polymorphs

To assess the relative stability of the polymorphs, lattice energy calculations were performed using the CrystalExplorer21 (version 21.5) [23] software, and the results are presented in Table 4. The data indicate that the stability is relatively similar among all polymorphs. Analyzing the intermolecular interaction energies between neighboring molecules (Table 3 and Figure S4) shows that, although the dispersion terms are not very large they accumulate and become the primary attractive force governing the crystal cohesion. Polymorph 3 shows the magnitude of the dispersion energy, which is enhanced by the stacking molecules found with separation distances shorter than the ∑vdW.
In terms of attraction, the Coulomb interaction has the second-largest contribution, which can be explained by the hydrogen bonds involved in the formation of R22(8) synthons. The Coulomb energy is relatively close in value to the dispersion terms and does not differ significantly between polymorphs.
The evaluation of the lattice energies is consistent with the polymorph densities and the packing index [32], with the exception of polymorph 4, which has a higher density and packing index than the other polymorphs, but a slightly lower lattice energy than polymorph 3.

4. Conclusions

The crystal structures of four polymorphs of the diuretic agent 4-chloro-5-chlorosulfonylsalicylic acid have been determined and reported. All crystals belong to centrosymmetric space groups: three belong to the monoclinic crystal system, with one being C2/c and two P21/c, while one belongs to the triclinic P-1 space group.
The asymmetric unit is comprised by one diuretic molecule in all polymorphs that are found to build molecular dimmers based on the R22(8) homosynthons, which are driven by strong mutual carboxyl···carboxyl O1-H1···O2 hydrogen bonds.
The analysis of the nature and strength of intermolecular interactions reveals that cohesion within the crystal lattices is primarily driven by dispersion forces associated with the stacking of molecular layers, complemented by strong electrostatic forces resulting from the presence of O-H···O hydrogen bonds, while polarization energies play a lesser role

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/cryst15020136/s1. Figure S1: Comparison between packing similarities between polymorphs; Figure S2: X-ray powder diffraction analysis comparison between experimental (Exp) and simulated (Sim) diffraction patterns: Polymorph 1 (a); Polymorph 2 (b); Polymorph 3 (c); Polymorph 4 (d); Figure S3: Front and back views of the electrostatic potential mapped on the Hirshfeld surfaces: Polymorph 1 (−0.065 to 0.244) (a); Polymorph 2 (−0.069 to 0.228) (b); Polymorph 3 (0.0613 to 0.2231) (c); Polymorph 4 (−0.0568 to 0.2295) (d); Figure S4: Intermolecular interaction energies for a molecular cluster with a radius of 3.8 Å: Polymorph 1 (a); Polymorph 2 (b); Polymorph 3 (c); Polymorph 4 (d). CIF files of the structures were deposited at the Cambridge Crystallographic Data Centre: 2410826 (Polymorph 1); 2410827 (Polymorph 2); 2410828 (Polymorph 3); 2410829 (Polymorph 4). The copies can be obtained free of charge by written application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK (fax:+44 1223 336033), or by accessing http://www.ccdc.cam.ac.uk (accessed on 19 January 2025).

Author Contributions

Conceptualization, A.T. and G.B.; methodology, G.B.; software, A.T.; validation, A.T., M.O.M. and G.B.; formal analysis, G.B. and M.O.M.; investigation, M.O.M.; resources, G.B.; data curation, A.T.; writing—original draft preparation, A.T. and G.B.; writing—review and editing, A.T.; visualization, G.B.; supervision, G.B.; project administration, G.B.; funding acquisition, A.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Ministry of Research, Innovation and Digitalization through the “Nucleu” Programe within the National Plan for Research, Development and Innovation 2022-2027, project PN23 24 01 01.

Data Availability Statement

On request via email to alexandru.turza@itim-cj.ro.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. War, A.R.; Paulraj, M.G.; War, M.Y.; Ignacimuthu, S. Role of Salicylic Acid in Induction of Plant Defense System in Chickpea (Cicer arietinum L.). Plant Signal. Behav. 2011, 6, 1787–1792. [Google Scholar] [CrossRef]
  2. Madan, R.K.; Levitt, J. A Review of Toxicity from Topical Salicylic Acid Preparations. J. Am. Acad. Dermatol. 2014, 70, 788–792. [Google Scholar] [CrossRef] [PubMed]
  3. Bilal, H.; Xiao, Y.; Khan, M.N.; Chen, J.; Wang, Q.; Zeng, Y.; Lin, X. Stabilization of Acne Vulgaris-Associated Microbial Dysbiosis with 2% Supramolecular Salicylic Acid. Pharmaceuticals 2023, 16, 87. [Google Scholar] [CrossRef] [PubMed]
  4. Andrýsková, N.; Motyčka, J.; Babincová, M.; Babinec, P.; Šimaljaková, M. Computational Design of a Novel Dithranol–Salicylic Acid Antipsoriatic Prodrug for Esterase-Activated Topical Drug Delivery. Appl. Sci. 2024, 14, 1094. [Google Scholar] [CrossRef]
  5. Măgerușan, Ș.E.; Hancu, G.; Rusu, A. A Comprehensive Bibliographic Review Concerning the Efficacy of Organic Acids for Chemical Peels Treating Acne Vulgaris. Molecules 2023, 28, 7219. [Google Scholar] [CrossRef] [PubMed]
  6. Kim, H.J.; Kim, Y.H. Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies. Int. J. Mol. Sci. 2024, 25, 5302. [Google Scholar] [CrossRef]
  7. Song, X.; Li, R.; Zhang, Q.; He, S.; Wang, Y. Antibacterial Effect and Possible Mechanism of Salicylic Acid Microcapsules against Escherichia Coli and Staphylococcus Aureus. Int. J. Environ. Res. Public Health 2022, 19, 12761. [Google Scholar] [CrossRef]
  8. Lebedev, A.A.; Bazhmina, M.Y.; Smirnov, V.A. Synthesis and Diuretic Activity of 4-Chlorosalicylic Acid Derivatives. Pharm. Chem. J. 1987, 21, 641–645. [Google Scholar] [CrossRef]
  9. Smith, R.L.; Woltersdorf, O.W.; Cragoe, E.J. Chapter 8: Diuretics. In Annual Reports in Medicinal Chemistry; Elsevier: Amsterdam, The Netherlands, 1976; Volume 11, pp. 71–79. ISBN 978-0-12-040511-4. [Google Scholar]
  10. Braun, D.E.; Karamertzanis, P.G.; Arlin, J.-B.; Florence, A.J.; Kahlenberg, V.; Tocher, D.A.; Griesser, U.J.; Price, S.L. Solid-State Forms of β-Resorcylic Acid: How Exhaustive Should a Polymorph Screen Be? Cryst. Growth Des. 2011, 11, 210–220. [Google Scholar] [CrossRef]
  11. Sarma, B.; Sanphui, P.; Nangia, A. Polymorphism in Isomeric Dihydroxybenzoic Acids. Cryst. Growth Des. 2010, 10, 2388–2399. [Google Scholar] [CrossRef]
  12. Turza, A.; Borodi, G.; Miclaus, M.O.; Kacso, I. Structural Studies of the Diuretic Compound 4-Chloro Salicylic Acid-5-Sulfonamide. J. Mol. Struct. 2020, 1212, 128154. [Google Scholar] [CrossRef]
  13. Montis, R.; Hursthouse, M.B. Surprisingly Complex Supramolecular Behaviour in the Crystal Structures of a Family of Mono-Substituted Salicylic Acids. CrystEngComm 2012, 14, 5242. [Google Scholar] [CrossRef]
  14. Alexandru, T.; Maria, M.O.; Liviu, Z.; Maria, D.; Irina, K.; Gheorghe, B. New Solid Forms of the Diuretic Compound 4-Chloro Salicylic Acid-5-Sulfonamide. J. Mol. Struct. 2021, 1241, 130682. [Google Scholar] [CrossRef]
  15. Bernstein, J. Polymorphism in Molecular Crystals, 2nd ed.; IUCr Monographs on Crystallography; Oxford University Press: Oxford, UK; New York, NY, USA, 2020; ISBN 978-0-19-965544-1. [Google Scholar]
  16. Artusio, F.; Contreras-Montoya, R.; Gavira, J.A. Advances in Pharmaceutical Crystals: Control over Nucleation and Polymorphism. Crystals 2024, 14, 805. [Google Scholar] [CrossRef]
  17. Chistyakov, D.; Sergeev, G. The Polymorphism of Drugs: New Approaches to the Synthesis of Nanostructured Polymorphs. Pharmaceutics 2020, 12, 34. [Google Scholar] [CrossRef]
  18. Tan, S.L.; Tan, Y.S.; Ng, J.H.; Dolzhenko, A.V.; Tiekink, E.R.T. Two Conformational polymorphs of a Bioactive Pyrazolol [3,4-d]pyrimidine. Crystals 2023, 13, 974. [Google Scholar] [CrossRef]
  19. Shi, P.; Han, Y.; Zhu, Z. Research progress on the Molecular Mechanism of Polymorph Nucleation in Solution: A Perspective from Research Mentality and Technique. Crystals 2023, 13, 1206. [Google Scholar] [CrossRef]
  20. Filho, A.S.; Martins, J.L.R.; Costa, R.F.; Pedrino, G.R.; Duarte, V.S.; Silva, O.N.; Napolitano, H.B.; Fajemiroye, J.O. Polymorphism and Pharmacological Assessment of Carmazepine. Int. J. Mol. Sci. 2024, 25, 9835. [Google Scholar] [CrossRef]
  21. Tan, S.L.; Tan, Y.S.; Shahari, M.S.; Junaid, A.; Dolzhenko, A.V.; Tiekink, E.R.T. Ethanol- and heat-mediated phase change from a kinetic (Z′ = 1) polymorph for N2,6-diaryl-1,3,5-triazine-2,4-diamine. CrystEngComm 2023, 25, 798–812. [Google Scholar] [CrossRef]
  22. CrysAlis PRO; Rigaku Oxford Diffraction: Yarnton, UK, 2015.
  23. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  24. Sheldrick, G.M. A Short History of SHELX. Acta Crystallogr. A Found. Crystallogr. 2008, 64, 112–122. [Google Scholar] [CrossRef] [PubMed]
  25. Sheldrick, G.M. SHELXT—Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  26. Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  27. Spackman, P.R.; Turner, M.J.; McKinnon, J.J.; Wolff, S.K.; Grimwood, D.J.; Jayatilaka, D.; Spackman, M.A. CrystalExplorer: A Program for Hirshfeld Surface Analysis, Visualization and Quantitative Analysis of Molecular Crystals. J. Appl. Crystallogr. 2021, 54, 1006–1011. [Google Scholar] [CrossRef] [PubMed]
  28. Mackenzie, C.F.; Spackman, P.R.; Jayatilaka, D.; Spackman, M.A. CrystalExplorer Model Energies and Energy Frameworks: Extension to Metal Coordination Compounds, Organic Salts, Solvates and Open-Shell Systems. IUCrJ 2017, 4, 575–587. [Google Scholar] [CrossRef]
  29. Hahn, T. International Tables for Crystallography, 5th ed.; Kluwer Academic Publishers: Dordrecht, The Netherlands, 2002; ISBN 978-0-7923-6590-7. [Google Scholar]
  30. Macrae, C.F.; Sovago, I.; Cottrell, S.J.; Galek, P.T.A.; McCabe, P.; Pidcock, E.; Platings, M.; Shields, G.P.; Stevens, J.S.; Towler, M.; et al. Mercury 4.0: From Visualization to Analysis, Design and Prediction. J. Appl. Crystallogr. 2020, 53, 226–235. [Google Scholar] [CrossRef]
  31. Chisholm, J.A.; Motherwell, S. COMPACK: A Program for Identifying Crystal Structure Similarity Using Distances. J. Appl. Crystallogr. 2005, 38, 228–231. [Google Scholar] [CrossRef]
  32. Spek, A.L. checkCIF validation ALERTS: What they mean and how to respond. Acta Crystallogr. Sect. E Crystallogr. Commun. 2020, 76, 1–11. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical diagram of 4-chloro-5-chlorosulfonyl salicylic acid polymorphs.
Figure 1. Chemical diagram of 4-chloro-5-chlorosulfonyl salicylic acid polymorphs.
Crystals 15 00136 g001
Figure 2. Polymorph 1 displaying the atomic numbering as thermal ellipsoids at 50% probability (a); crystal packing viewed along ob-axis (b).
Figure 2. Polymorph 1 displaying the atomic numbering as thermal ellipsoids at 50% probability (a); crystal packing viewed along ob-axis (b).
Crystals 15 00136 g002
Figure 3. Polymorph 2 displaying the atomic numbering as thermal ellipsoids at 50% probability (a); crystal packing viewed along oa-axis (b).
Figure 3. Polymorph 2 displaying the atomic numbering as thermal ellipsoids at 50% probability (a); crystal packing viewed along oa-axis (b).
Crystals 15 00136 g003
Figure 4. Polymorph 3 displaying the atomic numbering as thermal ellipsoids at 50% probability (a); crystal packing viewed along ob-axis (b).
Figure 4. Polymorph 3 displaying the atomic numbering as thermal ellipsoids at 50% probability (a); crystal packing viewed along ob-axis (b).
Crystals 15 00136 g004
Figure 5. Polymorph 4 displaying the atomic numbering as thermal ellipsoids at 50% probability (a); crystal packing viewed along ob-axis (b).
Figure 5. Polymorph 4 displaying the atomic numbering as thermal ellipsoids at 50% probability (a); crystal packing viewed along ob-axis (b).
Crystals 15 00136 g005
Figure 6. Front and rear perspectives of Hirshfeld surfaces of polymorphs mapped with dnorm in a range of −0.734 to 1.275 arbitrary units for Polymorph 1 (a), −0.703 to 1.393 arbitrary units for Polymorph 2 (b), −0.693 to 1.125 arbitrary units for Polymorph 3 (c), and −0.708 to 0.961 arbitrary units for Polymorph 4 (d).
Figure 6. Front and rear perspectives of Hirshfeld surfaces of polymorphs mapped with dnorm in a range of −0.734 to 1.275 arbitrary units for Polymorph 1 (a), −0.703 to 1.393 arbitrary units for Polymorph 2 (b), −0.693 to 1.125 arbitrary units for Polymorph 3 (c), and −0.708 to 0.961 arbitrary units for Polymorph 4 (d).
Crystals 15 00136 g006aCrystals 15 00136 g006b
Figure 7. Fingerprint plots of the polymorphs.
Figure 7. Fingerprint plots of the polymorphs.
Crystals 15 00136 g007
Figure 8. Breakdown of the fingerprint plots in individual contributions. Polymorph 1 (a); Polymorph 2 (b); Polymorph 3 (c); Polymorph 4 (d).
Figure 8. Breakdown of the fingerprint plots in individual contributions. Polymorph 1 (a); Polymorph 2 (b); Polymorph 3 (c); Polymorph 4 (d).
Crystals 15 00136 g008aCrystals 15 00136 g008b
Figure 9. Crystal packing views over a domain of 2 × 2 × 2 unit cells considering a scale factor of 100 and an energy cut-off of 8 kJ/mol, illustrating the electrostatic term (red), dispersion energy (green), and the overall energy frameworks (blue) of the polymorphs. The relative magnitude of interaction energies is proportional to the cylindrical radius. Polymorph 1 (a); Polymorph 2 (b); Polymorph 3 (c); Polymorph 4 (d).
Figure 9. Crystal packing views over a domain of 2 × 2 × 2 unit cells considering a scale factor of 100 and an energy cut-off of 8 kJ/mol, illustrating the electrostatic term (red), dispersion energy (green), and the overall energy frameworks (blue) of the polymorphs. The relative magnitude of interaction energies is proportional to the cylindrical radius. Polymorph 1 (a); Polymorph 2 (b); Polymorph 3 (c); Polymorph 4 (d).
Crystals 15 00136 g009aCrystals 15 00136 g009b
Table 1. Crystallographic and refinement details of analyzed polymorphs.
Table 1. Crystallographic and refinement details of analyzed polymorphs.
Identification CodePolymorph 1Polymorph 2Polymorph 3Polymorph 4
Empirical formulaC7H4Cl2O5SC7H4Cl2O5SC7H4Cl2O5SC7H4Cl2O5S
Formula weight271.06271.06271.06271.06
Temperature/K293(2)293(2)293(2)293(2)
Crystal systemmonoclinictriclinicmonoclinicmonoclinic
Space groupC2/cP-1P21/cP21/c
a/Å16.1353(7)7.6935(7)7.4495(3)5.9570(2)
b/Å7.3277(3)8.1150(7)8.5652(2)9.6985(3)
c/Å17.1273(7)8.7459(9)15.4974(5)16.8231(5)
α/°9081.717(8)9090
β/°95.571(4)68.786(9)97.386(3)95.364(3)
γ/°9079.410(8)9090
Volume/Å32015.48(15)498.57(9)980.63(6)967.68(5)
Z′1111
Z8244
ρcalcg/cm31.7871.8061.8361.861
μ/mm−17.7810.8560.8708.103
F(000)1088.0272.0544.0544.0
RadiationCuKα (λ = 1.54184)MoKα (λ = 0.71073)MoKα (λ = 0.71073)Cu Kα (λ = 1.54184)
2θ range for data collection/°10.378 to 142.8366.862 to 58.0767.124 to 58.13610.54 to 142.178
Index ranges−15 ≤ h ≤ 19, −8 ≤ k ≤ 4, −18 ≤ l ≤ 20−9 ≤ h ≤ 9, −11 ≤ k ≤ 9, −11 ≤ l ≤ 10−9 ≤ h ≤ 9, −11 ≤ k ≤ 11, −20 ≤ l ≤ 20−7 ≤ h ≤ 7, −11 ≤ k ≤ 11, −20 ≤ l ≤ 12
Reflections collected31143305130013406
Independent reflections1909 [Rint = 0.0140, Rsigma = 0.0230]2147 [Rint = 0.0372, Rsigma = 0.0643]2384 [Rint = 0.0458, Rsigma = 0.0372]1829 [Rint = 0.0206, Rsigma = 0.0301]
Data/restraints/parameters1909/0/1382147/4/1442384/2/1441829/0/139
Goodness-of-fit on F21.0501.0721.0781.049
Final R indexes [I ≥ 2σ (I)]R1 = 0.0344, wR2 = 0.0886R1 = 0.0565, wR2 = 0.1320R1 = 0.0628, wR2 = 0.1714R1 = 0.0359, wR2 = 0.0970
Final R indexes [all data]R1 = 0.0384, wR2 = 0.0926R1 = 0.0783, wR2 = 0.1656R1 = 0.0967, wR2 = 0.1967R1 = 0.0406, wR2 = 0.1032
Largest diff. peak/hole/e Å−30.32/−0.480.42/−0.620.72/−0.670.35/−0.33
Table 2. Normalized contact distances of intermolecular interactions of polymorphs shorter than the sum of the van der Waals radii.
Table 2. Normalized contact distances of intermolecular interactions of polymorphs shorter than the sum of the van der Waals radii.
Contactdnorm Distance (Å)∑vdW (Å)Δ(∑vdW-dnorm Distance)Symmetry Operation
Polymorph 1
O1-H1···O21.6662.720.944½ − x, ½ − y, −z
O3-H3···O52.4902.720.12x, 1 − y, −½ + z
C4-H4···O42.4452.720.165x, 1 + y, z
O4···C12.9043.220.316½ − x, ½ + y, ½ − z
O4···C23.1293.220.091½ − x, ½ + y, ½ − z
C1···Cl23.4093.450.0411 − x, y, ½ − y
Polymorph 2
O1-H1···O21.7052.720.9051 − x, 1 − y, -1 − z
O3-H3···O52.3872.720.2231 + x, y, −1 + z
C4-H4···O42.3082.720.3021 + x, y, z
Cl2···O33.2493.270.0211 − x, 2 − y, −z
Polymorph 3
O1-H1···O21.7182.720.892−x, −y, −z
C4-C4 (π-π)3.3933.400.0071 − x, 1 − y, −z
C7-H7···Cl22.9492.950.109−x, −½ + y, ½ − z
C7···O53.2133.220.0071 − x, −½ + y, ½ − z
Polymorph 4
O1-H1···O21.6982.720.912−x, 2 − y, 1 − z
O3-H3···O52.6062.720.004x, 1.5 − y, ½ + z
C7-H7···Cl22.9252.950.025−x, ½ + y, ½ − z
Cl1···Cl23.4253.500.0751 + x, y, z
O3···Cl23.2583.270.0121 − x, 1 − y, 1 − z
Table 3. Strength and nature of intermolecular interactions for some relevant contacts.
Table 3. Strength and nature of intermolecular interactions for some relevant contacts.
CrystalContactEeleEpolEdispErepEtot
Polymorph 1O1-H1···O2−115.0−19.9−11.587.6−59.8
O3-H3···O5−2.5−0.9−7.43.1−7.6
C4-H4···O4−4.7−1.4−11.57.1−10.5
O4···C1
O4···C2
−16.1−2.7−24.910.6−33.1
Cl2···C1−8.9−0.7−39.019.8−28.8
Polymorph 2O1-H1···O2−104.9−17.6−11.674.6−59.5
O3-H3···O5−5.3−1.0−7.24.5−9.0
C4-H4···O4−6.9−0.9−8.46.6−9.6
Cl2···O3−6.1−0.6−29.514.9−21.3
Polymorph 3O1-H1···O2−101.0−16.6−11.172.8−55.9
C4···C4 (π···π)−2.7−0.8−34.114.4−23.2
C7-H7···Cl2−4.1−1.1−13.50−18.7
C7···O5−7.6−2.3−11.94.5−17.3
Polymorph 4O1-H1···O2−107.4−19.1−11.579.9−58.1
O3-H3···O5−3.7−0.7−6.82.8−8.4
C7-H7···Cl2−12.8−1.4−11.27.4−18.0
Cl1···Cl24.3−1.0−18.69.4−5.9
O3···Cl2−2.8−0.7−33.015.0−21.5
Table 4. Comparison of lattice energy and the breakdown in individual energy terms for the four polymorphs.
Table 4. Comparison of lattice energy and the breakdown in individual energy terms for the four polymorphs.
StructureEcoul (kJ/mol)Epol (kJ/mol)Edisp (kJ/mol)Erep (kJ/mol)Elatt (kJ/mol)Density (g/cm3)Packing Index %
Polymorph 1−88.7−9.2−87.979.4−106.41.78768.5
Polymorph 2−81.4−6.0−98.077.1−108.31.80669.3
Polymorph 3−76.6−10.2−101.273.4−114.61.83670.8
Polymorph 4−82.2−10.3−97.380.5−109.31.86171.7
Abbreviations: Ecoul—the Coulombic term; Epol—the polarization term; Edisp—the dispersion term; Erep—the repulsion term; Elatt—crystal lattice energy.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Miclaus, M.O.; Borodi, G.; Turza, A. Four Polymorphs of the Bioactive Diuretic Drug 4-Chloro-5-chlorosulfonyl Salicylic Acid. Crystals 2025, 15, 136. https://doi.org/10.3390/cryst15020136

AMA Style

Miclaus MO, Borodi G, Turza A. Four Polymorphs of the Bioactive Diuretic Drug 4-Chloro-5-chlorosulfonyl Salicylic Acid. Crystals. 2025; 15(2):136. https://doi.org/10.3390/cryst15020136

Chicago/Turabian Style

Miclaus, Maria Olimpia, Gheorghe Borodi, and Alexandru Turza. 2025. "Four Polymorphs of the Bioactive Diuretic Drug 4-Chloro-5-chlorosulfonyl Salicylic Acid" Crystals 15, no. 2: 136. https://doi.org/10.3390/cryst15020136

APA Style

Miclaus, M. O., Borodi, G., & Turza, A. (2025). Four Polymorphs of the Bioactive Diuretic Drug 4-Chloro-5-chlorosulfonyl Salicylic Acid. Crystals, 15(2), 136. https://doi.org/10.3390/cryst15020136

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop